Can serologic markers of fibrosis reveal an arrhythmogenic ventricular substrate in nonischemic dilated cardiomyopathy?

J Am Coll Cardiol. 2010 Jun 15;55(24):2760-1. doi: 10.1016/j.jacc.2010.02.041.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Biomarkers / blood*
  • Cardiomyopathy, Dilated / blood*
  • Cardiomyopathy, Dilated / etiology
  • Cardiomyopathy, Dilated / therapy
  • Death, Sudden, Cardiac / prevention & control
  • Defibrillators, Implantable
  • Disease Progression
  • Electric Countershock / instrumentation*
  • Endomyocardial Fibrosis / blood*
  • Endomyocardial Fibrosis / complications
  • Endomyocardial Fibrosis / physiopathology
  • Humans
  • Prognosis
  • Ventricular Function, Left / physiology

Substances

  • Biomarkers